// App-Quantinova.ai

: Influence of GLP-1 analogue, liraglutide on MRI volume and cognition in patients with Alzheimer’s disease (Analysis from ELAD Study)

Researchers

Presenter

  • Paul Edison

Principal Investigators

  • Craig W. Ritchie

  • Clive Holmes

  • Joseph Nowell

  • Zuzana Walker

  • Basil H Ridha

  • Sanara Raza

  • Nicholas R Livingston

  • Gail Busza

  • Eleni Frangou

  • Sharon Love

  • Gareth Williams

  • Robert M Lawrence

  • Brady McFarlane

  • Hilary Archer

  • Elizabeth Coulthard

  • Ben Underwood

  • Paul Koranteng

  • Salman Karim

  • Carol Bannister

  • Robert Perneczky

  • Aparna Prasanna

  • Kehinde Junaid

  • Bernadette McGuinness

  • Ramin Nilforooshan

  • Ajayverma Macharouthu

  • Andrew Donaldson

  • Simon Thacker

  • Gregor Russell

  • Naghma Malik

  • Vandana Mate

  • Lucy Knight

  • Sajeev Kshemendran

  • Christian Holscher

  • Anita Mansouri

  • Mae Chester-Jones

  • Jane Holmes

  • Trisha Tan

  • Steven CR Williams

  • David J Brooks

  • John E Harrison

  • Rainer Hinz

  • George Tadros

  • Anthony Peter Passmore

  • Clive G Ballard

Medical Centers

  • South West London and St George's Mental Health NHS Trust

  • Cornwall Partnership NHS Foundation Trust, Truro, UK

  • Heart of England NHS Foundation Trust,

  • South Staffordshire and Shropshire Healthcare NHS Foundation Trust

  • Queens University, Belfast, UK

  • Newcastle University, NE

  • University of Exeter

  • University of Southampton,

  • Lancashire Care NHS Foundation Trust

  • Institute of Psychiatry, Psychology & Neuroscience, King's College London

  • Bradford District Care NHS Foundation Trust

  • NHS Lanarkshire

  • University CollegeLondon, UK

  • Nottinghamshire Healthcare NHS Foundation Trust

  • Henan University of Chinese Medicine

  • Ageing Research Group, Centre for Public Health, Queen's University Belfast

  • University of Oxford,

  • Imperial College, London, UK

  • North Bristol NHS Trust

  • Black Country Partnership NHS Foundation Trust

  • Cambridgeshire and Peterborough NHS Foundation Trust

  • University of Manchester

  • Edinburgh Dementia Prevention, University of Edinburgh

  • NHS Ayrshire and Arran

  • Neurology Imaging Unit, Imperial College London

  • Brighton & Sussex University Hospitals NHS Trust

  • Somerset Partnership NHS Foundation Trust

  • North West Boroughs Partnership NHS Foundation Trust

  • Derbyshire Healthcare NHS Foundation Trust

  • Southern Health NHS Foundation Trust

  • Kings College, London,

  • Surrey and Borders NHS Foundation Trust

  • Northamptonshire Healthcare NHS Foundation Trust

  • King’s College,

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

  • Dementia

Biomarkers

  • N/A

Drug/Treatment

  • Liraglutide

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • II

Study Id's

  • NCT01843075

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved